Biblio

Export 496 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Keyword is N  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
S. Tok, Ahnaou, A., and Drinkenburg, W., Functional Neurophysiological Biomarkers of Early-Stage Alzheimer's Disease: A Perspective of Network Hyperexcitability in Disease Progression., J Alzheimers Dis, vol. 88, no. 3, pp. 809-836, 2022.
S. Tholen, Schmaderer, C., Chmielewski, S., Förstl, H., Heemann, U., Baumann, M., Steubl, D., and Grimmer, T., Reduction of Amyloid-β Plasma Levels by Hemodialysis: An Anti-Amyloid Treatment Strategy?, J Alzheimers Dis, vol. 50, no. 3, pp. 791-6, 2016.
C. Themistocleous, Ficek, B., Webster, K., Ouden, D. - Bden, Hillis, A. E., and Tsapkini, K., Automatic Subtyping of Individuals with Primary Progressive Aphasia., J Alzheimers Dis, vol. 79, no. 3, pp. 1185-1194, 2021.
R. Thangavel, Bhagavan, S. M., Ramaswamy, S. Beladakere, Surpur, S., Govindarajan, R., Kempuraj, D., Zaheer, S., Raikwar, S., Ahmed, M. E., Selvakumar, G. Pushpavath, Iyer, S. S., and Zaheer, A., Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain., J Alzheimers Dis, vol. 61, no. 2, pp. 553-560, 2018.
N. Shu Ning Teoh, Gyanwali, B., Lai, M. K. P., Chai, Y. Ling, Chong, J. R., Chong, E. Jun Yi, Chen, C., Tan, C. Seng, and Hilal, S., Association of Interleukin-6 and Interleukin-8 with Cognitive Decline in an Asian Memory Clinic Population., J Alzheimers Dis, vol. 92, no. 2, pp. 445-455, 2023.
N. Shu Ning Teoh, Gyanwali, B., Lai, M. K. P., Chai, Y. Ling, Chong, J. R., Chong, E. Jun Yi, Chen, C., Tan, C. Seng, and Hilal, S., Association of Interleukin-6 and Interleukin-8 with Cognitive Decline in an Asian Memory Clinic Population., J Alzheimers Dis, vol. 92, no. 2, pp. 445-455, 2023.
A. F. Teich, Sakurai, M., Patel, M., Holman, C., Saeed, F., Fiorito, J., and Arancio, O., PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease., J Alzheimers Dis, vol. 52, no. 1, pp. 295-302, 2016.
A. F. Teich, Sakurai, M., Patel, M., Holman, C., Saeed, F., Fiorito, J., and Arancio, O., PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease., J Alzheimers Dis, vol. 52, no. 1, pp. 295-302, 2016.
C. - C. Tan, Zhang, X. - Y., Tan, L., and Yu, J. - T., Tauopathies: Mechanisms and Therapeutic Strategies., J Alzheimers Dis, vol. 61, no. 2, pp. 487-508, 2018.
M. T. Tam, Dosso, J. A., and Robillard, J. M., The Impact of a Global Pandemic on People Living with Dementia and Their Care Partners: Analysis of 417 Lived Experience Reports., J Alzheimers Dis, vol. 80, no. 2, pp. 865-875, 2021.
S. Takenoshita, Terada, S., Yokota, O., Kutoku, Y., Wakutani, Y., Nakashima, M., Maki, Y., Hattori, H., and Yamada, N., Sally-Anne Test in Patients with Alzheimer's Disease Dementia., J Alzheimers Dis, vol. 61, no. 3, pp. 1029-1036, 2018.
S
A. Synn, Mothakunnel, A., Kumfor, F., Chen, Y., Piguet, O., Hodges, J. R., and Irish, M., Mental States in Moving Shapes: Distinct Cortical and Subcortical Contributions to Theory of Mind Impairments in Dementia., J Alzheimers Dis, vol. 61, no. 2, pp. 521-535, 2018.
A. Suzuki, Stern, S. A., Bozdagi, O., Huntley, G. W., Walker, R. H., Magistretti, P. J., and Alberini, C. M., Astrocyte-neuron lactate transport is required for long-term memory formation., Cell, vol. 144, no. 5, pp. 810-23, 2011.
K. Surya, Manickam, N., Jayachandran, K. Swaminatha, Kandasamy, M., and Anusuyadevi, M., Resveratrol Mediated Regulation of Hippocampal Neuroregenerative Plasticity via SIRT1 Pathway in Synergy with Wnt Signaling: Neurotherapeutic Implications to Mitigate Memory Loss in Alzheimer's Disease., J Alzheimers Dis, vol. 94, no. s1, pp. S125-S140, 2023.
P. Suppa, Hampel, H., Kepp, T., Lange, C., Spies, L., Fiebach, J. B., Dubois, B., and Buchert, R., Performance of Hippocampus Volumetry with FSL-FIRST for Prediction of Alzheimer's Disease Dementia in at Risk Subjects with Amnestic Mild Cognitive Impairment., J Alzheimers Dis, vol. 51, no. 3, pp. 867-73, 2016.
E. E. Sundermann, Edmonds, E. C., Delano-Wood, L., Galasko, D. R., Salmon, D. P., Rubin, L. H., and Bondi, M. W., Sex Influences the Accuracy of Subjective Memory Complaint Reporting in Older Adults., J Alzheimers Dis, vol. 61, no. 3, pp. 1163-1178, 2018.
X. Sun, Suo, X., Xia, X., Yu, C., and Dou, Y., Dimethyl Fumarate is a Potential Therapeutic Option for Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 1, pp. 443-456, 2022.
X. Sun, Suo, X., Xia, X., Yu, C., and Dou, Y., Dimethyl Fumarate is a Potential Therapeutic Option for Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 1, pp. 443-456, 2022.
X. Sun, Suo, X., Xia, X., Yu, C., and Dou, Y., Dimethyl Fumarate is a Potential Therapeutic Option for Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 1, pp. 443-456, 2022.
E. Stogmann, Moser, D., Klug, S., Gleiss, A., Auff, E., Dal-Bianco, P., Pusswald, G., and Lehrner, J., Activities of Daily Living and Depressive Symptoms in Patients with Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 4, pp. 1043-50, 2016.
K. Stoeck, Psychogios, M. Nikos, Ohlenbusch, A., Steinfeld, R., and Schmidt, J., Late-Onset Metachromatic Leukodystrophy with Early Onset Dementia Associated with a Novel Missense Mutation in the Arylsulfatase A Gene., J Alzheimers Dis, vol. 51, no. 3, pp. 683-7, 2016.
C. Stockburger, Miano, D., Baeumlisberger, M., Pallas, T., Arrey, T. N., Karas, M., Friedland, K., and Müller, W. E., A Mitochondrial Role of SV2a Protein in Aging and Alzheimer's Disease: Studies with Levetiracetam., J Alzheimers Dis, vol. 50, no. 1, pp. 201-15, 2016.
C. Stockburger, Miano, D., Baeumlisberger, M., Pallas, T., Arrey, T. N., Karas, M., Friedland, K., and Müller, W. E., A Mitochondrial Role of SV2a Protein in Aging and Alzheimer's Disease: Studies with Levetiracetam., J Alzheimers Dis, vol. 50, no. 1, pp. 201-15, 2016.
C. Stockburger, Miano, D., Baeumlisberger, M., Pallas, T., Arrey, T. N., Karas, M., Friedland, K., and Müller, W. E., A Mitochondrial Role of SV2a Protein in Aging and Alzheimer's Disease: Studies with Levetiracetam., J Alzheimers Dis, vol. 50, no. 1, pp. 201-15, 2016.
R. A. Sperling, Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., Park, D. C., Reiman, E. M., Rowe, C. C., Siemers, E., Stern, Y., Yaffe, K., Carrillo, M. C., Thies, B., Morrison-Bogorad, M., Wagster, M. V., and Phelps, C. H., Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease., Alzheimers Dement, vol. 7, no. 3, pp. 280-92, 2011.

Pages